Prevention and Treatment of Infectious Complications After Solid Organ Transplantation in Children

Overview

Journal Pediatr Clin North Am

Specialty Pediatrics

Date 2010 Apr 8

PMID 20371047

Citations 4

Authors

Upton Allen

Michael Green

Affiliations

Soon will be listed here.

Abstract

Effective prevention, diagnosis, and treatment of infectious diseases after transplantation are key factors contributing to the success of organ transplantation. Most transplant patients experience different kinds of infections during the first year after transplantation. Children are at particular risk of developing some types of infections by virtue of lack of immunity although they may be at risk for other types due the effect of immunosuppressive regimens necessary to prevent rejection. Direct consequences of infections result in syndromes such as mononucleosis, pneumonia, gastroenteritis, hepatitis, among other entities. Indirect consequences are mediated through cytokines, chemokines, and growth factors elaborated by the transplant recipient in response to microbial replication and invasion, which contribute to the net state of immunosuppression among other effects. This review summarizes the major infections that occur after pediatric organ transplantation, highlighting the current treatment and prevention strategies, based on the available data and/or consensus.

Citing Articles

Severe Sepsis in Pediatric Liver Transplant Patients: The Emergence of Multidrug-Resistant Organisms.

Alcamo A, Alessi L, Vehovic S, Bansal N, Bond G, Carcillo J Pediatr Crit Care Med. 2019; 20(7):e326-e332.

PMID: 31094887 PMC: 6612583. DOI: 10.1097/PCC.0000000000001983.

Correlates of illness severity in infectious mononucleosis.

Odame J, Robinson J, Khodai-Booran N, Yeung S, Mazzulli T, Stephens D Can J Infect Dis Med Microbiol. 2014; 25(5):277-80.

PMID: 25371691 PMC: 4211352. DOI: 10.1155/2014/514164.

Minimizing infection risks after paediatric organ transplants: Advice for practitioners.

Allen U Paediatr Child Health. 2014; 18(3):143-54.

PMID: 24421679 PMC: 3680288.

Analysis of infections in the first 3-month after living donor liver transplantation.

Li C, Wen T, Mi K, Wang C, Yan L, Li B World J Gastroenterol. 2012; 18(16):1975-80.

PMID: 22563180 PMC: 3337575. DOI: 10.3748/wjg.v18.i16.1975.

References

Barton M, Wasfy S, Dipchand A, Hebert D, Ng V, Solomon M . Seven-valent pneumococcal conjugate vaccine in pediatric solid organ transplant recipients: a prospective study of safety and immunogenicity. Pediatr Infect Dis J. 2009; 28(8):688-92. DOI: 10.1097/INF.0b013e31819d97be. View

Danziger-Isakov L, Delamorena M, Hayashi R, Sweet S, Mendeloff E, Schootman M . Cytomegalovirus viremia associated with death or retransplantation in pediatric lung-transplant recipients. Transplantation. 2003; 75(9):1538-43. DOI: 10.1097/01.TP.0000061607.07985.BD. View

Baum D, Bernstein D, Starnes V, Oyer P, Pitlick P, Stinson E . Pediatric heart transplantation at Stanford: results of a 15-year experience. Pediatrics. 1991; 88(2):203-14. View

Arslan M, Wiesner R, Sievers C, Egan K, Zein N . Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease. Liver Transpl. 2001; 7(4):314-20. DOI: 10.1053/jlts.2001.23069. View

Olson A, Shope T, Flynn J . Pretransplant varicella vaccination is cost-effective in pediatric renal transplantation. Pediatr Transplant. 2001; 5(1):44-50. DOI: 10.1034/j.1399-3046.2001.00032.x. View

Okada K, Mao T, Mori T, Miura T, Sugiyama T, Yoshiyama T . Performance of an interferon-gamma release assay for diagnosing latent tuberculosis infection in children. Epidemiol Infect. 2007; 136(9):1179-87. PMC: 2870918. DOI: 10.1017/S0950268807009831. View

Weinberg A, Horslen S, Kaufman S, Jesser R, Devoll-Zabrocki A, Fleckten B . Safety and immunogenicity of varicella-zoster virus vaccine in pediatric liver and intestine transplant recipients. Am J Transplant. 2006; 6(3):565-8. DOI: 10.1111/j.1600-6143.2005.01210.x. View

Green M . Management of Epstein-Barr virus-induced post-transplant lymphoproliferative disease in recipients of solid organ transplantation. Am J Transplant. 2002; 1(2):103-8. View

Verma A, Wade J, Cheeseman P, Samaroo B, Rela M, Heaton N . Risk factors for fungal infection in paediatric liver transplant recipients. Pediatr Transplant. 2005; 9(2):220-5. DOI: 10.1111/j.1399-3046.2005.00295.x. View

10.

. Outbreak of swine-origin influenza A (H1N1) virus infection - Mexico, March-April 2009. MMWR Morb Mortal Wkly Rep. 2009; 58(17):467-70. View

11.

Green M, Michaels M, Katz B, Burroughs M, Gerber D, Shneider B . CMV-IVIG for prevention of Epstein Barr virus disease and posttransplant lymphoproliferative disease in pediatric liver transplant recipients. Am J Transplant. 2006; 6(8):1906-12. DOI: 10.1111/j.1600-6143.2006.01394.x. View

12.

de Mezerville M, Tellier R, Richardson S, Hebert D, Doyle J, Allen U . Adenoviral infections in pediatric transplant recipients: a hospital-based study. Pediatr Infect Dis J. 2006; 25(9):815-8. DOI: 10.1097/01.inf.0000233542.48267.fd. View

13.

Humar A, Morris M, Blumberg E, Freeman R, Preiksaitis J, Kiberd B . Nucleic acid testing (NAT) of organ donors: is the 'best' test the right test? A consensus conference report. Am J Transplant. 2010; 10(4):889-899. DOI: 10.1111/j.1600-6143.2009.02992.x. View

14.

Scalera N, Mossad S . The first pandemic of the 21st century: a review of the 2009 pandemic variant influenza A (H1N1) virus. Postgrad Med. 2009; 121(5):43-7. DOI: 10.3810/pgm.2009.09.2051. View

15.

Asberg A, Humar A, Jardine A, Rollag H, Pescovitz M, Mouas H . Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients. Am J Transplant. 2009; 9(5):1205-13. DOI: 10.1111/j.1600-6143.2009.02617.x. View

16.

. Report from the Advisory Committee on Immunization Practices (ACIP): decision not to recommend routine vaccination of all children aged 2-10 years with quadrivalent meningococcal conjugate vaccine (MCV4). MMWR Morb Mortal Wkly Rep. 2008; 57(17):462-5. View

17.

Pandya A, Wasfy S, Hebert D, Allen U . Varicella-zoster infection in pediatric solid-organ transplant recipients: a hospital-based study in the prevaricella vaccine era. Pediatr Transplant. 2001; 5(3):153-9. DOI: 10.1034/j.1399-3046.2001.00048.x. View

18.

Schaenman J, Rosso F, Austin J, Baron E, Gamberg P, Miller J . Trends in invasive disease due to Candida species following heart and lung transplantation. Transpl Infect Dis. 2009; 11(2):112-21. DOI: 10.1111/j.1399-3062.2009.00364.x. View

19.

Green M, Wald E, Fricker F, Griffith B, Trento A . Infections in pediatric orthotopic heart transplant recipients. Pediatr Infect Dis J. 1989; 8(2):87-93. View

20.

LiPuma J . Update on the Burkholderia cepacia complex. Curr Opin Pulm Med. 2005; 11(6):528-33. DOI: 10.1097/01.mcp.0000181475.85187.ed. View